Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa M Wolf

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Oncogene|March 4, 2020
Modeling clear cell renal cell carcinoma and therapeutic implicationsMelissa M Wolf, W Kimryn Rathmell, Kathryn E Beckermann
Nature Reviews. Nephrology|March 27, 2023
Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigensMelissa M Wolf, W Kimryn Rathmell, Aguirre A de Cubas
Biorxiv : the Preprint Server for Biology|November 19, 2025
MDR1 promotes CD8 T cell persistence in tumors and protects against cytotoxic chemotherapyLincoln A Brown, Megan M Erwin, Natalie R Favret, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Tissue-Specific Dependence of Th1 Cells on the Amino Acid Transporter SLC38A1 in InflammationAyaka Sugiura, Katherine L Beier, Channing Chi, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
TCF1 <sup>lo</sup> CD8 T cells proliferate and persist autonomously in tumorsMegan M Erwin, Natalie R Favret, Claudia N McDavid, et al.
Cell Metabolism|March 24, 2026
Tissue and CD4 T cell subset dependence on the amino acid transporter SLC38A1Ayaka Sugiura, Katherine L Beier, Channing Chi, et al.
The Journal of Clinical Investigation|June 28, 2024
HIF-2α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinomaZachary A Bacigalupa, Emily N Arner, Logan M Vlach, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Pre-division TCF1 drop determines long-term CD8 T cell fatesNatalie R Favret, Maider Astorkia, Melissa M Wolf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2023
Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T CellsMatthew Z Madden, Xiang Ye, Channing Chi, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 23, 2018
Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial CellsQin Zhang, Dennis K Jeppesen, James N Higginbotham, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Oncogene|March 4, 2020
Modeling clear cell renal cell carcinoma and therapeutic implicationsMelissa M Wolf, W Kimryn Rathmell, Kathryn E Beckermann
Nature Reviews. Nephrology|March 27, 2023
Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigensMelissa M Wolf, W Kimryn Rathmell, Aguirre A de Cubas
Biorxiv : the Preprint Server for Biology|November 19, 2025
MDR1 promotes CD8 T cell persistence in tumors and protects against cytotoxic chemotherapyLincoln A Brown, Megan M Erwin, Natalie R Favret, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Tissue-Specific Dependence of Th1 Cells on the Amino Acid Transporter SLC38A1 in InflammationAyaka Sugiura, Katherine L Beier, Channing Chi, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
TCF1 <sup>lo</sup> CD8 T cells proliferate and persist autonomously in tumorsMegan M Erwin, Natalie R Favret, Claudia N McDavid, et al.
Cell Metabolism|March 24, 2026
Tissue and CD4 T cell subset dependence on the amino acid transporter SLC38A1Ayaka Sugiura, Katherine L Beier, Channing Chi, et al.
The Journal of Clinical Investigation|June 28, 2024
HIF-2α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinomaZachary A Bacigalupa, Emily N Arner, Logan M Vlach, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Pre-division TCF1 drop determines long-term CD8 T cell fatesNatalie R Favret, Maider Astorkia, Melissa M Wolf, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2023
Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T CellsMatthew Z Madden, Xiang Ye, Channing Chi, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 23, 2018
Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial CellsQin Zhang, Dennis K Jeppesen, James N Higginbotham, et al.
Pageof 2